Predictors of optimal cognitive aging in 80+ women: The women's health initiative memory study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue , 2016, Pages S62-S71

  Goveas, Joseph S ^a   Rapp, Stephen R ^b   Hogan, Patricia E ^b   Driscoll, Ira ^c   Tindle, Hilary A ^d   Smith, J Carson ^e   Kesler, Shelli R ^f   Zaslavsky, Oleg ^g   Rossom, Rebecca C ^h   Ockene, Judith K ⁱ   Yaffe, Kristine ^j   Manson, Joann E ^k   Resnick, Susan M ^l   Espeland, Mark A ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF HAIFA   (Israel)

^h HEALTHPARTNERS INSTITUTE   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l NATIONAL INSTITUTE ON AGING   (United States)

more..

Author keywords

Cognition; Cognitive aging; Successful aging

Indexed keywords

AGING; COGNITION; COGNITION DISORDERS; DISABILITY; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS; HEALTH SURVEY; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; RISK FACTOR; UNITED STATES; VERY ELDERLY; WOMEN'S HEALTH;

AGED, 80 AND OVER; AGING; COGNITION; COGNITION DISORDERS; DISABILITY EVALUATION; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS; HEALTH SURVEYS; HUMANS; QUALITY OF LIFE; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 85015598616     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv055     Document Type: Article

References (43)

1. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995;273:1354-1359.
2. Yaffe K, Middleton LE, Lui LY, et al. Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol. 2011;68:631-636. doi:10.1001/archneurol.2011.82
3. Yaffe K, Lindquist K, Vittinghoff E, et al. The effect of maintaining cognition on risk of disability and death. J Am Geriatr Soc. 2010; 58:889-894. doi:10.1111/j.1532-5415.2010.02818.x
4. Fiocco AJ, Yaffe K. Defining successful aging: the importance of including cognitive function over time. Arch Neurol. 2010;67:876-880. doi:10.1001/archneurol.2010.130
5. Albert MS, Jones K, Savage CR, et al. Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging. 1995;10:578-589.
6. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003;22:13-22.
7. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819-828. doi:10.1016/S1474-4422(11)70072-2
8. Barnes DE, Cauley JA, Lui LY, et al. Women who maintain optimal cognitive function into old age. J Am Geriatr Soc. 2007;55:259-264.
9. Yaffe K, Fiocco AJ, Lindquist K, et al. Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology. 2009;72:2029-2035. doi:10.1212/WNL.0b013e3181a92c36
10. Shumaker SA, Reboussin BA, Espeland MA, et al. The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials. 1998;19:604-621.
11. Rapp SR, Legault C, Espeland MA, et al. Validation of a cognitive assessment battery administered over the telephone. J Am Geriatr Soc. 2012;60:1616-1623. doi:10.1111/j.1532-5415.2012.04111.x
12. Ellis RJ, Jan K, Kawas C, et al. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol. 1998;55:360-365.
13. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012;44:955-959. doi:10.1038/ng.2354
14. Yuan Y. Multiple imputation using SAS software. J Statist Software. 2011;45:1-25.
15. Zeki Al Hazzouri A, Vittinghoff E, Byers A, et al. Long-term cumulative depressive symptom burden and risk of cognitive decline and dementia among very old women. J Gerontol A Biol Sci Med Sci. May 2014;69(5):595-601. doi:10.1093/gerona/glt139
16. Breitner JC, Wyse BW, Anthony JC, et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 1999;53:321-331.
17. Dolan D, Troncoso J, Resnick SM, Crain BJ, Zonderman AB, O'Brien RJ. Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain. 2010;133(Pt 8):2225-2231. doi:10.1093/brain/awq141
18. Berlau DJ, Corrada MM, Robinson JL, et al. Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old. Alzheimers Dement. 2013;9:699-705. doi:10.1016/j.jalz.2012.11.011
19. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336-342. doi:10.1001/archneurol.2008.582
20. Wang S, Luo X, Barnes D, Sano M, Yaffe K. Physical activity and risk of cognitive impairment among oldest-old women. Am J Geriatr Psychiatry. November 2014;22(11):1149-1157. doi:10.1016/j.jagp.2013.03.002
21. Christensen K, Thinggaard M, Oksuzyan A, et al. Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet. 2013;382:1507-1513. doi:10.1016/S0140-6736(13)60777-1
22. Osorio RS, Pirraglia E, Aguera-Ortiz LF, et al. Greater risk of Alzheimer's disease in older adults with insomnia. J Am Geriatr Soc. 2011;59:559-562. doi:10.1111/j.1532-5415.2010.03288.x
23. Tworoger SS, Lee S, Schernhammer ES, Grodstein F. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord. 2006;20:41-48.
24. Jaussent I, Bouyer J, Ancelin ML, et al. Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep. 2012;35:1201-1207. doi:10.5665/sleep.2070
25. Naidoo N, Ferber M, Master M, Zhu Y, Pack AI. Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J Neurosci. 2008;28:6539-6548. doi:10.1523/JNEUROSCI. 5685-07.2008
26. Kang JE, Lim MM, Bateman RJ, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326:1005-1007. doi:10.1126/science.1180962
27. Spira AP, Gamaldo AA, An Y, et al. Self-reported sleep and beta-amyloid deposition in community-dwelling older adults. JAMA Neurology. 2013; 70: 1537-1543. doi:10.1001/jamaneurol.2013.4258
28. Ferrie JE, Shipley MJ, Akbaraly TN, Marmot MG, Kivimaki M, Singh-Manoux A. Change in sleep duration and cognitive function: findings from the Whitehall II Study. Sleep. 2011;34:565-573.
29. Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 2011;306:613-619. doi:10.1001/jama.2011.1115
30. Levine DW, Kripke DF, Kaplan RM, et al. Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess. 2003;15:137-148.
31. Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology- a bidirectional relationship. Nat Rev Neurol. 2014;10:115-119. doi:10.1038/nrneurol.2013.269
32. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012;11:1006-1012. doi:10.1016/S1474-4422(12)70191-6
33. Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry. 2006;14:6-20.
34. Bowling A, Dieppe P. What is successful ageing and who should define it? BMJ. 2005;331:1548-1551.
35. Montross LP, Depp C, Daly J, et al. Correlates of self-rated successful aging among community-dwelling older adults. Am J Geriatr Psychiatry. 2006;14:43-51.
36. Woods NF, Cochrane BB, LaCroix AZ, et al. Toward a positive aging phenotype for older women: observations from the women's health initiative. J Gerontol A Biol Sci Med Sci. 2012;67:1191-1196. doi:10.1093/gerona/gls117
37. Zaslavsky O, Cochrane BB, Woods NF, et al. Trajectories of positive aging: observations from the women's health initiative study. Int Psychogeriatr. 2014;26:1-12. doi:10.1017/S1041610214000593
38. Tindle H, Davis E, Kuller L. Attitudes and cardiovascular disease. Maturitas. 2010;67:108-113. doi:10.1016/j.maturitas.2010.04.020
39. Espeland MA, Brunner RL, Hogan PE, et al. Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension. J Am Geriatr Soc. 2010;58:1263-1271. doi:10.1111/j.1532-5415.2010.02953.x
40. Espeland MA, Tindle HA, Bushnell CA, et al. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci. 2009;64:1243-1250. doi:10.1093/gerona/glp128
41. Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMSMRI Study. Neurology. 2009;72:135-142. doi:10.1212/01. wnl.0000339037.76336.cf
42. Glatt SJ, Chayavichitsilp P, Depp C, Schork NJ, Jeste DV. Successful aging: from phenotype to genotype. Biol Psychiatry. 2007;62:282-293.
43. Espeland MA, Pettinger M, Falkner KL, et al. Demographic and health factors associated with enrollment in posttrial studies: the Women's Health Initiative Hormone Therapy Trials. Clin Trials. 2013;10:463-472. doi:10.1177/1740774513477931